XEnd Medical Systems mission is to reduce the incidence of infections caused by hypodermic needle injections. Invented by a world-renowned eye surgeon, the “Antibacterial Hypodermic Needle and Syringe (AHNS)” is designed to prevent bacteria on the surface from being transported to the body’s interior by a hypodermic needle. This is a serious problem for patients receiving injections of medication into spaces with little ability to fight infection, including the eye, certain joints, cerebrospinal fluid and any injection where the patient is severely immunosuppressed. Bodily fluids withdrawn via needle and syringe are also susceptible to bacterial infection, causing a serious, prevalent and costly problem for physicians performing blood cultures. The AHNS is expected to drive better patient outcomes and to sharply lower treatment and liability costs.